✦ LIBER ✦

P.5.d.005 Role of cannabinoid CB2 receptor in Parkinson's disease

✍ Scribed by Navarrete Rueda, F.; García-Gutiérrez, M.S.; Aracil-Fernández, A.; Molina-Arjona, J.A.; Leiva-Santana, C.; Manzanares, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.3.f.005 A2A-adenosine, D2-dopamine and

✍ L. Urigüen; M.J. García-Fuster; L.F. Callado; B. Morentin; R. La Harpe; V. Casad 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Anti-dyskinetic effects of cannabinoids

✍ Maria Grazia Morgese; Tommaso Cassano; Vincenzo Cuomo; Andrea Giuffrida 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 650 KB

P.5.d.005 Reduced dopamine transporter b

✍ Van den Heuvel, O.A.; Vriend, C.; Nordbeck, A.H.; Booij, J.; Van der Werf, Y.D.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Effects of rimonabant, a selective canna

✍ Sara González; Camila Scorticati; Moisés García-Arencibia; Rosario de Miguel; Jo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 331 KB

Striatal Cannabinoid CB1 Receptor mRNA E

✍ M.A. Silverdale; S. McGuire; A. McInnes; A.R. Crossman; J.M. Brotchie 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 145 KB

P.1.005 Role of cannabinoid CB1 receptor

✍ Licheri, V.; Talani, G.; Dazzi, L.; Biggio, F.; Utzeri, C.; Lallai, V.; Lutzu, S 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 45 KB